Trifluperidol Hydrochloride

盐酸三氟哌多

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTrifluperidol Hydrochloride
Drug Alias Name盐酸氟哌利多trifluperidolum盐酸三氟哌利多trifluperidol盐酸三氟多哌
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsSchizophrenia
Approved Indications in ChinaSchizophrenia
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesChina Resources Double-Crane Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN05AD02
Related LinksKEGG